Privia Health Group, Inc. (NASDAQ:PRVA) Holdings Raised by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. lifted its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 0.6% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 593,817 shares of the company’s stock after acquiring an additional 3,795 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.49% of Privia Health Group worth $11,609,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently modified their holdings of the business. XTX Topco Ltd purchased a new position in Privia Health Group during the third quarter valued at approximately $182,000. Barclays PLC increased its stake in shares of Privia Health Group by 240.3% in the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after acquiring an additional 158,188 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Privia Health Group by 1.0% during the third quarter. Geode Capital Management LLC now owns 2,415,022 shares of the company’s stock worth $43,986,000 after acquiring an additional 23,178 shares in the last quarter. Virtu Financial LLC acquired a new stake in Privia Health Group during the third quarter valued at $263,000. Finally, Franklin Resources Inc. grew its stake in Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after purchasing an additional 28,480 shares in the last quarter. Hedge funds and other institutional investors own 94.48% of the company’s stock.

Insiders Place Their Bets

In other Privia Health Group news, CFO David Mountcastle sold 5,630 shares of the business’s stock in a transaction dated Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the transaction, the chief financial officer now directly owns 179,676 shares in the company, valued at $4,021,148.88. The trade was a 3.04 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 14.20% of the company’s stock.

Privia Health Group Price Performance

Privia Health Group stock opened at $23.68 on Friday. The business has a 50 day simple moving average of $23.83 and a 200 day simple moving average of $21.63. The company has a market capitalization of $2.87 billion, a PE ratio of 236.82, a price-to-earnings-growth ratio of 3.47 and a beta of 0.88. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $26.04.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Canaccord Genuity Group boosted their price target on Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, February 28th. Piper Sandler raised their price target on shares of Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, February 28th. Barclays lifted their price objective on shares of Privia Health Group from $21.00 to $23.00 and gave the company an “equal weight” rating in a research note on Thursday, April 10th. Stephens reissued an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a research report on Thursday, January 2nd. Finally, Needham & Company LLC reissued a “buy” rating and set a $30.00 target price on shares of Privia Health Group in a research report on Thursday, April 10th. One analyst has rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $27.00.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.